glp-1 news november 3 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo The GLP-1 Access Gap: Mapping

Endocrinology 155, 28582867

For age-related macular degeneration, findings were dichotomous, suggesting a protective effect against non-exudative forms but a potential increased risk for neovascular disease

doi: 10.1038/nature11740 199 VelmuruganK.BalamuruganA

Tiny lunches

Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program 70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss and overall health gains The program addresses all three major barriers to bending the obesity curve in the US: excessive US prices of medication, medication side effects, and sustainable lifestyle change NEW YORK, Aug

The FDAs intent to act on non-approved GLP-1 products reinforces patient safety and regulatory rigor